Identifying groups at high risk for carriage of antibiotic-resistant bacteria

被引:79
作者
Furuno, JP
McGregor, JC
Harris, AD
Johnson, JA
Johnson, JK
Langenberg, P
Venezia, RA
Finkelstein, J
Smith, DL
Strauss, SM
Perencevich, EN
机构
[1] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[3] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA
[4] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA
关键词
D O I
10.1001/archinte.166.5.580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: No simple, cost-effective methods exist to identify patients at high risk for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization outside intensive care settings. Without such methods, colonized patients are entering hospitals undetected and transmitting these bacteria to other patients. We aimed to develop a highly sensitive, simple-to-administer prediction rule to identify subpopulations of patients at high risk for colonization on hospital admission. Methods: We conducted a prospective cohort study of adult patients admitted to the general medical and surgical wards of a tertiary-care facility. Data were collected using electronic medical records and an investigator-administered questionnaire. Cultures of anterior nares and the perirectal area were also collected within 48 hours of admission. Results: Among 699 patients who enrolled in this study, 697 underwent nasal cultures; 555, perirectal cultures; and 553, both. Patient self-report of a hospital admission in the previous year was the most sensitive variable in identifying patients colonized with methicillin-resistant Staphylococcus aureus or with either organism ( sensitivity, 76% and 90%, respectively). A prediction rule requiring patients to self-report having received antibiotics and a hospital admission in the previous year would have identified 100% of patients colonized with vancomycin-resistant enterococci. In the high-risk groups defined by the prediction rule, the prevalence of colonization by methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, or either organism were 8.1%, 10.2%, and 15.0%, respectively. Conclusion: Patients with a self-reported previous admission within 1 year may represent a high-risk group for colonization by methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci at hospital admission and should be considered for targeted active surveillance culturing.
引用
收藏
页码:580 / 585
页数:6
相关论文
共 22 条
[1]  
[Anonymous], CONS PRIC IND
[2]  
*CDCP, 1999, VANC RES ENT VRE CLI
[3]  
*CDCP, 1999, LAB DET OX METH RES
[4]  
Centers for Disease Control and Prevention, 2003, Morbidity Mortality Weekly Report, V52, P992
[5]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P919
[6]   Control of endemic methicillin-resistant Staphylococcus aureus -: A cost-benefit analysis in an intensive care unit [J].
Chaix, C ;
Durand-Zaleski, I ;
Alberti, C ;
Brun-Buisson, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1745-1751
[7]   Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection [J].
Davis, KA ;
Stewart, JJ ;
Crouch, HK ;
Florez, CE ;
Hospenthal, DR .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :776-782
[8]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[9]   Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission [J].
Furuno, JP ;
Harris, AD ;
Wright, MO ;
McGregor, JC ;
Venezia, RA ;
Zhu, JK ;
Perencevich, EN .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :436-440
[10]   Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients [J].
Harris, AD ;
Perencevich, E ;
Roghmann, MC ;
Morris, G ;
Kaye, KS ;
Johnson, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :854-858